VanEck Associates’s VanEck Pharmaceutical ETF PPH Stock Holding History

VanEck Associates’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-24	Closed	-$2K	–	1420
2024 Q3	$2K	Sell	24 -1	-4%	-$95	﹤0.01%	1370
2024 Q2	$2K	Sell	25 -5	-17%	-$446	﹤0.01%	1366
2024 Q1	$3K	Sell	30 -34	-53%	-$2.98K	﹤0.01%	1355
2023 Q4	$5K	Hold	64	–	–	﹤0.01%	1365
2023 Q3	$5K	Hold	64	–	–	﹤0.01%	1374
2023 Q2	$5K	Hold	64	–	–	﹤0.01%	1380
2023 Q1	$5K	Buy	64 +13	+25%	+$1K	﹤0.01%	1386
2022 Q4	$4K	Hold	51	–	–	﹤0.01%	1404
2022 Q3	$3K	Hold	51	–	–	﹤0.01%	1369
2022 Q2	$4K	Hold	51	–	–	﹤0.01%	1341
2022 Q1	$4K	Hold	51	–	–	﹤0.01%	1337
2021 Q4	$4K	Buy	+51	New	+$3.79K	﹤0.01%	1346

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return

MTWSIF

Mivtachim The Workers Social Insurance Fund Tel Aviv, Israel $789M AUM 73.25% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

VanEck Associates's PPH Position: Q4 2024 in Review

VanEck Associates sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2024, closing a stake of 24 shares — an estimated $2K sold.

VanEck Associates first reported a position in PPH in Q4 2021 and held it in 12 quarters. The position peaked at $5K in Q4 2023. 142 funds tracked by Wall St. Rank hold PPH as of Q4 2024.

VanEck Associates reported no remaining VanEck Pharmaceutical ETF position as of Q4 2024 after selling out during the quarter.
VanEck Associates sold 24 VanEck Pharmaceutical ETF shares in Q4 2024, an estimated $2K.
VanEck Associates first reported a position in VanEck Pharmaceutical ETF in Q4 2021 and held it in 12 quarters.
VanEck Associates's VanEck Pharmaceutical ETF position peaked at $5K in Q4 2023.
142 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2024.

Based on VanEck Associates's 13F filing for Q4 2024, filed 29 Jan 2025.